Health: Prostate-Cancer Prevention--with Risks

Say there's a drug that could significantly lower your risk of prostate cancer. Say it could also increase your chance of growing particularly aggressive tumors--those most likely to spread and kill--if you do get cancer. Should you take it? That's the question doctors and patients have been wrestling with since the results of a National Cancer Institute--sponsored trial were published last week in the New England Journal of Medicine. Compared with a placebo, Merck's finasteride--a drug currently marketed to treat baldness and benign prostate enlargement--appeared to reduce prostate cancer incidence 25%. But in the seven-year study, involving more than 9,000 men...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!